CLSI I/LA25 A2 : 2011
Current
The latest, up-to-date edition.
MATERNAL SERUM SCREENING
Hardcopy , PDF
English
28-04-2011
Important note : Users cannot be edited or removed once added to your Multi user PDF.
Abstract
Committee Membership
Foreword
1 Scope
2 Introduction
3 Standard Precautions
4 Terminology
5 Specimen Collection
6 Screening Markers
7 Maternal Serum Screening for Open Netural Tube Defects
8 Screening for Trisomy 21
9 Relationship of False-Positive Screen Test to Adverse
Outcome
10 Quality Control
11 Management of Women With Screen-Positive Results
12 Incidental Detection of Edwards Syndrome (Trisomy 18)
13 Program Evaluation
References
Appendix - Amniotic Fluid Alpha-fetoprotein for Detection of
Open Neural Tube Defects
The Quality Management System Approach
Related CLSI Reference Materials
This standard specifies requirements and recommendations for maternal serum aspects of prenatal screening for neural tube defects (NTDs) and trisomy 21 (T21) (Down syndrome [DS]) and incorporates ultrasound measurements to ensure that screening methods and quality control procedures are carried out to a high standard.
| DevelopmentNote |
Supersedes NCCLS I/LA25 A. (05/2011)
|
| DocumentType |
Standard
|
| ISBN |
1-56238-749-9
|
| Pages |
64
|
| PublisherName |
Clinical Laboratory Standards Institute
|
| Status |
Current
|
| Supersedes |
| CLSI M29 A3 : 3ED 2005 | ACQUIRED INFECTIONS; APPROVED GUIDELINE |
| CLSI C24 A3 : 3ED 2006 | STATISTICAL QUALITY CONTROL FOR QUANTITATIVE MEASUREMENT PROCEDURES: PRINCIPLES AND DEFINITIONS |
| CLSI EP9 A2 : 2ED 2002 | METHOD COMPARISON AND BIAS ESTIMATION USING PATIENT SAMPLES |
Access your standards online with a subscription
Features
-
Simple online access to standards, technical information and regulations.
-
Critical updates of standards and customisable alerts and notifications.
-
Multi-user online standards collection: secure, flexible and cost effective.